AI-Enhanced Anti-Mycobacterial Therapy System

A novel system integrating oligo(carbamoylated guanidine)s (OCGs) with artificial intelligence (AI), Internet of Things (IoT), blockchain, and machine learning to create a personalized, adaptive, and secure anti-mycobacterial treatment platform.

The current TB treatment regimen is lengthy and rigorous due to difficulties associated with Mycobacterium tuberculosis (Mtb) resistance. The original patent introduced OCGs as a promising anti-mycobacterial agent, but its efficacy and treatment outcomes can be improved by integrating it with advanced technologies.

The AI-enhanced system comprises OCGs, AI for personalized medicine, IoT-enabled sensors for real-time monitoring, a blockchain-secured data storage system, and a machine learning algorithm for predicting mycobacterial resistance patterns. The AI optimizes OCG dosages based on patient-specific genomic data, while the IoT sensors track treatment efficacy and adjust dosages accordingly. The blockchain system ensures data integrity and utilizes novel, OCG-resistant materials for storing data. The machine learning algorithm predicts resistance patterns, enabling proactive treatment adjustments.

The new claims introduce a synergistic combination of OCGs with AI, IoT, blockchain, and machine learning, which is not obvious from the original patent. The integration of these distinct technologies creates a novel, more powerful system that addresses the limitations of the original patent.

Alternative embodiments may include using different AI algorithms, integrating with other IoT devices, or utilizing alternative blockchain platforms. Variations may include adapting the system for other infectious diseases or incorporating additional technologies, such as nanotechnology or gene editing.

The AI-enhanced anti-mycobacterial therapy system has significant commercial potential in the pharmaceutical and healthcare industries, particularly in developing countries where TB is prevalent. The system's ability to provide personalized, adaptive, and secure treatment can improve treatment outcomes, reduce healthcare costs, and enhance patient quality of life.